An audit of iodinated contrast media allergy of a medical center in Taiwan

Research output: Contribution to conferencePaper

Abstract

Background and Aims: Previous literatures revealed that mild hypersensitivity reactions (e.g. skin rashes, urticaria, nausea etc) to radiologic contrast media incidence was < 3%, ) and moderate to severe (e.g. laryngeal edema, tachycardia or bradycardia, cardiac failure, etc) incidence was < 0.04%). Mortality is less than one death per 100000 patients. The audit report aims to determine the frequency, management, and outcomes of allergy of intravenously injected iodinated contrast medium. Methods: Between 2008 and 2014,a total of 4384 patients in Group A (ionic contrast) (vs. 51654, Group B, non-ionic) received contrast medium examinations (CT and intravenous urography) were analyzed. The incident reports, radiology reports, and medical records of patients in whom contrast medium extravasations occurred were reviewed. Results: There were 134 injections in Group A (ionic, 4384 injections) and 244 injections (non-ionic, 51654 injections) in Group B. Allergic-like reaction rates were 0.68% [n=378]: mild, 2.6% [n=114] and in Group A vs 0.40% [n=207] in Group B; moderate/severe, 0.46% [n=20] and in Group A vs 0.07% [n=37] in Group B. Conclusion: The frequency of allergy decreases with use of non-ionic contrast media. The use of nonionic iodinated contrast medium has lesser in moderate or severe adverse effects than ionic contrast medium.
Original languageEnglish
Publication statusPublished - Nov 2015
EventAsia-Pacific Forum on Quality and Safety of Medical Imaging 2015 - Taipei, Taiwan
Duration: Nov 14 2014Nov 15 2014
http://www.nrst.tw/news/news_info.asp?id=553

Conference

ConferenceAsia-Pacific Forum on Quality and Safety of Medical Imaging 2015
Abbreviated titleAPQS 2015
CountryTaiwan
CityTaipei
Period11/14/1411/15/14
Internet address

Fingerprint

Taiwan
Contrast Media
Hypersensitivity
Injections
Laryngeal Edema
Urography
Incidence
Urticaria
Bradycardia
Radiology
Tachycardia
Nausea
Medical Records
Heart Failure
Mortality

Cite this

Lu, C. H., Chen, C-Y., & Chan, W. P. (2015). An audit of iodinated contrast media allergy of a medical center in Taiwan. Paper presented at Asia-Pacific Forum on Quality and Safety of Medical Imaging 2015 , Taipei, Taiwan.

An audit of iodinated contrast media allergy of a medical center in Taiwan. / Lu, Chia Hsun; Chen, Chia-Yuen; Chan, Wing P.

2015. Paper presented at Asia-Pacific Forum on Quality and Safety of Medical Imaging 2015 , Taipei, Taiwan.

Research output: Contribution to conferencePaper

Lu, CH, Chen, C-Y & Chan, WP 2015, 'An audit of iodinated contrast media allergy of a medical center in Taiwan' Paper presented at, Taipei, Taiwan, 11/14/14 - 11/15/14, .
Lu CH, Chen C-Y, Chan WP. An audit of iodinated contrast media allergy of a medical center in Taiwan. 2015. Paper presented at Asia-Pacific Forum on Quality and Safety of Medical Imaging 2015 , Taipei, Taiwan.
Lu, Chia Hsun ; Chen, Chia-Yuen ; Chan, Wing P. / An audit of iodinated contrast media allergy of a medical center in Taiwan. Paper presented at Asia-Pacific Forum on Quality and Safety of Medical Imaging 2015 , Taipei, Taiwan.
@conference{6f8cedcb622a4f8e9518563d4117a4f5,
title = "An audit of iodinated contrast media allergy of a medical center in Taiwan",
abstract = "Background and Aims: Previous literatures revealed that mild hypersensitivity reactions (e.g. skin rashes, urticaria, nausea etc) to radiologic contrast media incidence was < 3{\%}, ) and moderate to severe (e.g. laryngeal edema, tachycardia or bradycardia, cardiac failure, etc) incidence was < 0.04{\%}). Mortality is less than one death per 100000 patients. The audit report aims to determine the frequency, management, and outcomes of allergy of intravenously injected iodinated contrast medium. Methods: Between 2008 and 2014,a total of 4384 patients in Group A (ionic contrast) (vs. 51654, Group B, non-ionic) received contrast medium examinations (CT and intravenous urography) were analyzed. The incident reports, radiology reports, and medical records of patients in whom contrast medium extravasations occurred were reviewed. Results: There were 134 injections in Group A (ionic, 4384 injections) and 244 injections (non-ionic, 51654 injections) in Group B. Allergic-like reaction rates were 0.68{\%} [n=378]: mild, 2.6{\%} [n=114] and in Group A vs 0.40{\%} [n=207] in Group B; moderate/severe, 0.46{\%} [n=20] and in Group A vs 0.07{\%} [n=37] in Group B. Conclusion: The frequency of allergy decreases with use of non-ionic contrast media. The use of nonionic iodinated contrast medium has lesser in moderate or severe adverse effects than ionic contrast medium.",
author = "Lu, {Chia Hsun} and Chia-Yuen Chen and Chan, {Wing P.}",
year = "2015",
month = "11",
language = "English",
note = "null ; Conference date: 14-11-2014 Through 15-11-2014",
url = "http://www.nrst.tw/news/news_info.asp?id=553",

}

TY - CONF

T1 - An audit of iodinated contrast media allergy of a medical center in Taiwan

AU - Lu, Chia Hsun

AU - Chen, Chia-Yuen

AU - Chan, Wing P.

PY - 2015/11

Y1 - 2015/11

N2 - Background and Aims: Previous literatures revealed that mild hypersensitivity reactions (e.g. skin rashes, urticaria, nausea etc) to radiologic contrast media incidence was < 3%, ) and moderate to severe (e.g. laryngeal edema, tachycardia or bradycardia, cardiac failure, etc) incidence was < 0.04%). Mortality is less than one death per 100000 patients. The audit report aims to determine the frequency, management, and outcomes of allergy of intravenously injected iodinated contrast medium. Methods: Between 2008 and 2014,a total of 4384 patients in Group A (ionic contrast) (vs. 51654, Group B, non-ionic) received contrast medium examinations (CT and intravenous urography) were analyzed. The incident reports, radiology reports, and medical records of patients in whom contrast medium extravasations occurred were reviewed. Results: There were 134 injections in Group A (ionic, 4384 injections) and 244 injections (non-ionic, 51654 injections) in Group B. Allergic-like reaction rates were 0.68% [n=378]: mild, 2.6% [n=114] and in Group A vs 0.40% [n=207] in Group B; moderate/severe, 0.46% [n=20] and in Group A vs 0.07% [n=37] in Group B. Conclusion: The frequency of allergy decreases with use of non-ionic contrast media. The use of nonionic iodinated contrast medium has lesser in moderate or severe adverse effects than ionic contrast medium.

AB - Background and Aims: Previous literatures revealed that mild hypersensitivity reactions (e.g. skin rashes, urticaria, nausea etc) to radiologic contrast media incidence was < 3%, ) and moderate to severe (e.g. laryngeal edema, tachycardia or bradycardia, cardiac failure, etc) incidence was < 0.04%). Mortality is less than one death per 100000 patients. The audit report aims to determine the frequency, management, and outcomes of allergy of intravenously injected iodinated contrast medium. Methods: Between 2008 and 2014,a total of 4384 patients in Group A (ionic contrast) (vs. 51654, Group B, non-ionic) received contrast medium examinations (CT and intravenous urography) were analyzed. The incident reports, radiology reports, and medical records of patients in whom contrast medium extravasations occurred were reviewed. Results: There were 134 injections in Group A (ionic, 4384 injections) and 244 injections (non-ionic, 51654 injections) in Group B. Allergic-like reaction rates were 0.68% [n=378]: mild, 2.6% [n=114] and in Group A vs 0.40% [n=207] in Group B; moderate/severe, 0.46% [n=20] and in Group A vs 0.07% [n=37] in Group B. Conclusion: The frequency of allergy decreases with use of non-ionic contrast media. The use of nonionic iodinated contrast medium has lesser in moderate or severe adverse effects than ionic contrast medium.

M3 - Paper

ER -